High serum miR-19a levels are associated with inflammatory breast cancer and are predictive of favorable clinical outcome in patients with metastatic HER2+ inflammatory breast cancer.
about
New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid BiopsiesHsa-miR-19a is associated with lymph metastasis and mediates the TNF-α induced epithelial-to-mesenchymal transition in colorectal cancerAssociation of microRNA-93, 190, 200b and receptor status in core biopsies from stage III breast cancer patients.Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer.Circulating microRNA-19a as a potential novel biomarker for diagnosis of acute myocardial infarctionPrediction of poor prognosis in breast cancer patients based on microRNA-21 expression: a meta-analysis.Critical analysis of the potential for microRNA biomarkers in breast cancer management.Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring.Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer CellsmicroRNA Expression in Prospectively Collected Blood as a Potential Biomarker of Breast Cancer Risk in the BCFR.MicroRNA regulation of proteoglycan function in cancer.Breast cancer circulating biomarkers: advantages, drawbacks, and new insights.miR-141-Mediated Regulation of Brain Metastasis From Breast Cancer.Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients.MicroRNA-19a acts as a prognostic marker and promotes prostate cancer progression via inhibiting VPS37A expression.The fundamental role of miR-10b in metastatic cancer
P2860
Q26748881-9D053861-CF8C-4C60-8A03-82F3ED9DD3CFQ33552969-2D3056C6-81E2-40E1-9423-0DA18B4AB1C4Q34088205-BAA7256E-8E68-4A08-BDF9-ED4AE15385E3Q34645569-99C58DC0-0156-42BF-A2AF-43E2381002C6Q34685379-A7751770-8BF4-4E86-9722-CD99A7BA3C4BQ35112630-77E2AC2E-CCEC-48B9-901F-9BEEDF8B6559Q35137273-30FD901C-AE34-4E77-A16E-91D226DB186EQ35203556-A3408ADC-2EE9-4FBA-B142-FC53A7BA21FAQ35710589-BD3B9379-555E-46C5-9AF4-5F7155963999Q36647044-E6F4A419-0AB3-4A01-AF72-4978DAE7EE54Q38244283-1C7E30B7-7C71-4D80-9099-C0867F86D600Q38573871-47FDAC0D-652C-4DE6-9B46-F62ED502D57CQ38778447-80C0D931-9958-4EAC-A5C8-133FF8A2F0DAQ48096559-D81DD1D1-6E18-49C4-B127-399C9B29389EQ49243847-12FEDE3E-BB53-4755-8C68-7B048EE8528FQ57494141-23DDAC1B-EC96-4857-8DE5-D84F0F4C59D8
P2860
High serum miR-19a levels are associated with inflammatory breast cancer and are predictive of favorable clinical outcome in patients with metastatic HER2+ inflammatory breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
High serum miR-19a levels are ...... 2+ inflammatory breast cancer.
@en
High serum miR-19a levels are ...... 2+ inflammatory breast cancer.
@nl
type
label
High serum miR-19a levels are ...... 2+ inflammatory breast cancer.
@en
High serum miR-19a levels are ...... 2+ inflammatory breast cancer.
@nl
prefLabel
High serum miR-19a levels are ...... 2+ inflammatory breast cancer.
@en
High serum miR-19a levels are ...... 2+ inflammatory breast cancer.
@nl
P2093
P2860
P50
P1433
P1476
High serum miR-19a levels are ...... 2+ inflammatory breast cancer.
@en
P2093
Bisrat G Debeb
Gabriel N Hortobagyi
James M Reuben
Naoto T Ueno
Raul J Garza
Ricardo H Alvarez
Simone Anfossi
P2860
P304
P356
10.1371/JOURNAL.PONE.0083113
P407
P577
2014-01-08T00:00:00Z